Lisanti Capital Growth, LLC Medpace Holdings, Inc. Transaction History

Lisanti Capital Growth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$372.0 - $424.34 $695,640 - $793,515	-1,870 Reduced 52.09%	1,720 $708,000
Q1 2024 May 06, 2024	SELL	$284.87 - $413.31 $15,667 - $22,732	-55 Reduced 1.51%	3,590 $1.45 Million
Q4 2023 Feb 06, 2024	SELL	$227.52 - $312.68 $2.31 Million - $3.17 Million	-10,140 Reduced 73.56%	3,645 $1.12 Million
Q3 2023 Nov 02, 2023	BUY	$233.98 - $281.67 $3.23 Million - $3.88 Million	13,785 New	13,785 $3.34 Million
Q4 2021 Feb 04, 2022	SELL	$182.74 - $227.9 $2.43 Million - $3.03 Million	-13,315 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$170.18 - $198.21 $2.27 Million - $2.64 Million	13,315 New	13,315 $2.52 Million
Q3 2018 Nov 05, 2018	SELL	$43.25 - $63.74 $304,912 - $449,367	-7,050 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$34.03 - $45.46 $239,911 - $320,493	7,050 New	7,050 $303,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.